Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Hepatitis e? 148 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Hepatitis e have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.1% of all adverse event reports for CYCLOPHOSPHAMIDE.

148
Reports of Hepatitis e with CYCLOPHOSPHAMIDE
0.1%
of all CYCLOPHOSPHAMIDE reports
17
Deaths
55
Hospitalizations

How Dangerous Is Hepatitis e From CYCLOPHOSPHAMIDE?

Of the 148 reports, 17 (11.5%) resulted in death, 55 (37.2%) required hospitalization.

Is Hepatitis e Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 148 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Hepatitis e?

TACROLIMUS (366) PREDNISOLONE (333) MYCOPHENOLATE MOFETIL (266) RITUXIMAB (213) METHOTREXATE (183) PREDNISONE (172) RIBAVIRIN (166) MYCOPHENOLIC ACID (102) CYCLOSPORINE (96) DEXAMETHASONE (90)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Hepatitis e Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Hepatitis e Reports All Drugs Causing Hepatitis e CYCLOPHOSPHAMIDE Demographics